InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
7
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
-0.8%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Hedrick Marc H, Chairman & CEO. Officer active across 2 companies, notably Plus Therapeutics, INC.. In total, 13 reports have been logged. Split: 7 buys · 1 sell. Total volume traded: €52k. History available since 30 April 2021. The latest transaction was filed on 1 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hedrick Marc H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
159,681 shares0Common StockSEC:0001193125-26-135710:0
201,632 shares0Common StockSEC:0001193125-26-135710:1
159,681 shares0Common StockSEC:0001193125-26-000967:0
159,681 shares0Common StockSEC:0001193125-25-230296:0
8,000 shares@ US$1.229915.1% of flowCommon StockSEC:0000950170-24-105331:0
Canonical exit: 9 Dec 2024 (T+90)
12,255 shares@ US$2.0439.3% of flowCommon StockSEC:0000950170-24-057455:0
Canonical exit: 6 Aug 2024 (T+90)
2,068 shares@ US$1.95976.3% of flowCommon StockSEC:0001209191-23-058816:0
5,000 shares@ US$0.6480.0086% mcap13.3% of flowCommon StockSEC:0001209191-22-037240:0
Canonical exit: 13 Sept 2022 (T+90)
2,500 shares@ US$0.68410.0045% mcap6.9% of flowCommon StockSEC:0001209191-22-025901:0
Canonical exit: 25 Jul 2022 (T+90)
5,000 shares@ US$0.690.0090% mcap13.9% of flowCommon StockSEC:0001209191-22-025718:0
Canonical exit: 25 Jul 2022 (T+90)
2,500 shares@ US$1.65996.9% of flowCommon StockSEC:0001209191-21-061724:0
Canonical exit: 24 Jan 2022 (T+90)
2,183 shares@ US$2.27678.0% of flowCommon StockSEC:0001209191-21-029409:0
Canonical exit: 29 Jul 2021 (T+90)
70,500 sharesCommon StockSEC:0001140361-16-049630:0
13 of 13 declarations
About Hedrick Marc H
Marc H. Hedrick is the Chief Executive Officer of Plus Therapeutics, Inc. He leads the company by overseeing all operations and developing strategies for growth. His role is crucial for ensuring the success of the organization and meeting stakeholder needs.
